| Target Price | $3.06 |
| Price | $0.44 |
| Potential |
589.19%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target VolitionRX 2026 .
The average VolitionRX target price is $3.06.
This is
589.19%
register free of charge
$5.25
1,082.43%
register free of charge
$2.53
468.69%
register free of charge
|
|
| A rating was issued by 11 analysts: 9 Analysts recommend VolitionRX to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the VolitionRX stock has an average upside potential 2026 of
589.19%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 1.23 | 5.23 |
| 57.69% | 325.53% | |
| EBITDA Margin | -2,091.06% | -299.98% |
| 52.83% | 85.65% | |
| Net Margin | -2,192.68% | -393.11% |
| 51.58% | 82.07% |
8 Analysts have issued a sales forecast VolitionRX 2025 . The average VolitionRX sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an VolitionRX EBITDA forecast 2025. The average VolitionRX EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 VolitionRX Analysts have issued a net profit forecast 2025. The average VolitionRX net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.31 | -0.20 |
| 38.00% | 35.48% | |
| P/E | negative | |
| EV/Sales | 11.30 |
8 Analysts have issued a VolitionRX forecast for earnings per share. The average VolitionRX EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Sep 29 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Sep 10 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Aug 15 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Jul 09 2025 |
| Jones Trading |
Locked
➜
Locked
|
Locked | Jun 10 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 30 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Sep 29 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Sep 10 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Aug 15 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Jul 17 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Jul 09 2025 |
|
Locked
Jones Trading:
Locked
➜
Locked
|
Jun 10 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


